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OCCASIONAL REVIEW
Promotion of smoking cessation in developing countries: a
framework for urgent public health interventions
A S M Abdullah, C G Husten
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The rapid rise in smoking in many developing countries will
have devastating consequences; by 2030 the developing
world is expected to have 7 million deaths annually from
tobacco use. Many smokers express a desire to quit, but
they often fail because they are addicted to tobacco.
Although a number of cessation aids are now available in
the developed world, their applicability and affordability in
developing countries is less clear. Successful interventions
will require many stakeholder groups to take action at the
local, national, and international levels. We discuss
smoking cessation as a means of reducing disease burden,
examine factors that may limit the promotion of smoking
cessation in developing countries, and propose a
framework for public health action. This framework should
comprise intervention with healthcare professionals,
strengthening national commitment, development of a
model for developing countries, changing the social
acceptability of smoking, strengthening community
participation, integration of smoking cessation with other
healthcare services, specifying the role of healthcare
professionals, development of guidelines, mobilisation of
the business community, provision of financial incentives,
establishing population specific smoking cessation services,
increased collaboration between countries, and
development of international initiatives.
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D
eveloping countries (those with low and
middle incomes) whose current population
totals some 4.9 billion1 face a rapidly
growing epidemic of tobacco use; rates began
increasing in these countries in the early 1970s
(fig 1).2 In 1995, 82% of the world’s 1.1 billion
smokers lived in the developing world2 where the
prevalence of smoking in men and women
averaged 49% and 9%, respectively.3 In 2000,
4.83 million premature deaths in the world were
attributable to smoking, with 2.41 million deaths
in developing countries.4 The World Health
Organization (WHO) predicts that, if current
patterns of consumption continue, more than
500 million people alive today will be killed by
tobacco by 2030.3 Thus, tobacco control—parti-
cularly cessation interventions—will need to be a
priority for policy makers in developing countries
if a substantial impact is to be made within the
next few decades on the morbidity and mortality
caused by tobacco. Unfortunately, many barriers
must be overcome for cessation strategies to be
implemented broadly and successfully within a
comprehensive approach to tobacco control.
Importance of smoking cessation in
reducing disease burden
Smoking cessation is a priority for preventing
disease and reducing its burden.5–8 At any age,
quitting confers substantial and immediate
health benefits including reduced cardiovascular
disease risk,9 improved lipid profiles and platelet
reactivity,10 and reduced risk of stroke9 and
smoking attributable cancers.10 The World Bank
suggests that, if adult consumption were to
decrease by 50% by the year 2020, approximately
180 million tobacco related deaths could be
avoided.3 Thus, promotion of smoking cessation
and treatment of tobacco dependence can have a
great impact in reducing the burden of disease4
and improving population health.
According to the Commission on
Macroeconomics and Health (a WHO publica-
tion), smoking is on a short list of specific
conditions—including HIV/AIDS, malaria, tuber-
culosis, childhood infectious disease, maternal
and perinatal conditions, and micronutrient
deficiencies—that need to be a priority in low
income countries to save millions of lives, reduce
poverty, spur economic development, and pro-
mote global security.11 In addition, cessation
interventions are described specifically in the
draft Framework Convention on Tobacco Control
(FCTC); signing the FCTC and its ratification will
obligate countries to work on cessation as part of
a comprehensive effort in tobacco prevention and
control.12
Need for interventions to increase
cessation
Tobacco dependence is recognised as a disease in
the WHO’s International Classification of
Diseases (ICD-10)13 and the American
Psychiatric Association’s Diagnostic and
Statistical Manual (DSM-IV).14 In developed
countries a large proportion of smokers want to
stop smoking15 and many try to stop,16 but the
corresponding proportions in developing coun-
tries are low.17–19 Quit rates (the proportion of
ever smokers who have quit) are also low in
many developing countries.2 3 Smokers who try
to quit often find it difficult because of the
addictive properties of nicotine.19 20 Because of
the low rates of quitting and the inherent
difficulties in stopping, governments need to
encourage smokers to quit and to provide more
assistance to those who need help.
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Evidence base for effective interventions
The evidence base for both the effectiveness and cost
effectiveness of clinical smoking cessation interventions is
strong in Europe21 and the US.6 22–24 A similar evidentiary base
is not available for developing countries,25 but the recom-
mended clinical interventions have been shown to work in
diverse populations in the US (although the extent to which
tailoring could increase effectiveness has not been well
studied).21
In the US there is also a strong evidence base for the
effectiveness of community based and population based
interventions such as running sustained mass media cam-
paigns, raising tobacco prices, reducing the cost of treatment,
and establishing telephone quit lines.26 27 Some data on these
interventions are also available from other countries,
particularly for countermarketing campaigns, complete bans
on advertising, and taxation.28 29 Incorporating some of these
interventions within national tobacco control strategies
should be feasible in developing countries.26 30 Brazil31 and
Thailand32 have successfully implemented such interventions
within the national tobacco control programme.
In low and middle income countries a 10% increase in price
decreases consumption by an estimated 8%,29 an effect
double that seen in high income countries. This reduction
represents a combination of fewer young people starting to
smoke, fewer cigarettes being smoked by those who continue
to smoke, and increased cessation.27 29 Tax increases have the
added benefit of providing resources to the government,
which may be particularly important in resource poor
countries; such funding could help to support other tobacco
prevention and control activities.29
Policies to establish smoke free indoor air provide a social
environment that encourages non-smoking. Smoke free
policies have been clearly shown to decrease cigarette
consumption, and some data suggest that smoke free policies
may increase cessation.26 33 Clean indoor air restrictions are
moderately feasible but may be harder to enforce in
developing countries because of a smaller formal labour
sector.34 Decreasing out-of-pocket costs for cessation treat-
ment increases the number of smokers who try to quit as well
as the number of successful quitters;27 this cost barrier may
be particularly important in developing countries. The studies
are all from the US, but several were done among low income
smokers. Advertising bans may reduce the cues to smoke,25
and total bans on advertising reduce consumption while
partial bans have no effect.28 Because control of smuggling
preserves revenue from tobacco taxation and keeps tobacco
prices higher (thereby reducing consumption),35 establishing
such control is a highly relevant strategy for low income
countries.34 In addition, countermarketing campaigns have
been shown to increase cessation,27 and at least four
countermarketing studies outside the US have also demon-
strated their effectiveness in increasing cessation.28
SMOKING CESSATION AND THE DEVELOPING
WORLD
The developed and developing countries vary greatly in the
proportion of their smokers who have quit smoking. For
example, in developed (high income) countries 30% of men
were former smokers in 1993, while in 1996 less than 4% of
Chinese smokers were former smokers. Only 5% of Indian
men had quit in 1992–4, and only 10% of Vietnamese men
had quit in 1997.2 3 Intention to quit among adult smokers in
the developed world is as high as 75%,16 while in the
developing world it is generally much lower (14–16% in
China and 31% in India).17–19 This may be related to historical
differences in smoking between the developed countries
(where prevalence is declining) and developing countries
(where prevalence is still increasing). Lopez and colleagues
divided the tobacco epidemic into four different stages36:
N Stage 1: smoking prevalence less than 15% for men and
below 5% for women (the developing countries in sub-
Saharan Africa are now in this stage).
N Stage 2: smoking prevalence 50–80% in men and increas-
ing in women (China, Japan, and a number of other
countries in Asia, Latin America, and North Africa are now
in this stage).
N Stage 3: smoking prevalence declines to about 40% in
men; in women smoking prevalence peaks, plateaus, and
then starts to decline (Eastern European and Southern
European countries are now in this stage).
N Stage 4: smoking rates slowly decline in both sexes; male
mortality from smoking peaks and female mortality begins
to rise rapidly (USA, Canada, Australia, and developed
countries of Western Europe are now in this stage).
Promoting smoking cessation, creating an environment
supportive of non-smoking, and providing appropriate
services has produced encouraging results in the UK,37 the
US,38 and Hong Kong.39 Although in 2000 the WHO
recommended that the treatment of tobacco dependence be
considered a public health priority,40 much more needs to be
done to promote smoking cessation in the countries of the
developing world.
OBSTACLES TO PROMOTING SMOKING CESSATION
IN DEVELOPING COUNTRIES
Important obstacles to the promotion of smoking cessation in
developing countries include:
N economic factors;
N lack of awareness by policy makers of the health
consequences and costs of tobacco;
N low perception of risks among the public;
N lack of policies that promote cessation;
N smoking behaviour of service providers and their own lack
of knowledge or awareness;
N poor healthcare systems;
N lack of infrastructure; and
N industry action.
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Figure 1 Trends in per capita adult (age 15 years and over) cigarette
consumption in the world and in developed and developing countries,
1970–2 to 1990–2.
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Economic barriers: governmental and individual
To help with their debt burden, many low income countries
are shifting towards exportable cash crops including
tobacco.41 Tobacco is grown in 80 developing countries, in
which production increased 128% from 1975 to 1998.42
Tobacco companies are also investing in developing countries
by building manufacturing plants.41 The economic impact of
the tobacco industry can be substantial—for example, major
exporters of tobacco leaf such as Malawi, Zimbabwe, and
Tanzania receive 60%, 23%, and 4%, respectively, of their total
export earnings from tobacco.41 42 These economic forces
work against implementing strong tobacco control policies
and programmes. However, the impact of the tobacco
economy is often overestimated; even in Africa, most
countries spend more on tobacco imports than they earn
from exports.41 For net importers a reduction in tobacco use
would be expected to create jobs overall—for example,
Bangladesh has reported increasing employment with lower
tobacco demand.42 In developing countries the average
foreign exchange earnings from tobacco are 0.16% of gross
domestic product.34 Thus, in most countries, even very
stringent tobacco control efforts will have minimal negative
economic effects.42 In net exporters such as India, Kenya,
Malwai, Tanzania, and Zimbabwe, however, tobacco control
efforts could have a negative economic impact; the greatest
impact would be in the few countries with a significant share
of foreign earnings from tobacco, chiefly Malawi and
Zimbabwe.42
In low income countries it may be difficult to implement
proven but more expensive interventions such as quit lines,
sustained mass media campaigns, insurance coverage for
treatment (particularly medication), and research on the
local adverse health and economic effects of tobacco.34
Low socioeconomic status is also a barrier to accessing
health care, medication, or other forms of assistance in
quitting, and developed countries have shown an increasing
concentration of smoking in the lower socioeconomic
groups.43 Historically, tobacco use has started in higher social
classes, diffused generally through the population, and then
become concentrated in the lower social classes as the
hazards of tobacco use become more widely understood.36 44
Correspondingly, patterns of use in countries still in the
earlier stages of the tobacco epidemic may be more
homogeneous by class than they are in developed countries.
Nevertheless, in nearly all countries—both developing and
developed—smoking is more common among poor men (as
defined by income, education, occupation, or social class)
than rich men. In women the relationship between smoking
and poverty varies, probably because the onset of tobacco use
by women is more recent.45
Lack of awareness of health impacts by policy makers
and low public perceptions of risk
In developing countries policy makers may not be aware that
tobacco use has adverse consequences, both economically
and for health; this lack of information, in turn, hinders
tobacco prevention and control efforts in the country.34 A
contributing factor is the lack of local research on the health
and economic costs of tobacco,34 and an inappropriate belief
of policy makers that tobacco control interventions are less
urgent than action on other diseases.41
In low income countries public awareness of the health
hazards of tobacco is also low.46 In 1996 two thirds of adult
Chinese smokers believed cigarettes did ‘‘little or no harm’’.18
In addition, low education levels in many developing
countries may make it harder for people to understand the
hazards of tobacco use.47 The lack of local studies showing
harm also impairs dissemination of health information.47
Even when such information is disseminated, people under-
estimate the risk of smoking compared with other causes of
death.46 Studies in the US also demonstrate an inadequate
understanding of the addictive properties of tobacco use46 47
and show that, at least early on, smokers often think they can
quit smoking whenever they wish.8 In addition, the public is
frequently unaware of the availability of treatments for
tobacco dependence.48 These data suggest that smokers need
to be informed of the dangers of tobacco use and the health
promoting aspects of cessation and encouraged to seek
assistance if they have difficulty in quitting.
Lack of policies that support cessation
Tobacco control efforts in the developing world have mostly
concentrated on increasing tobacco taxes, restricting or
banning advertising, adding or expanding warning messages,
and restricting smoking in certain venues, but implementa-
tion of these policies has been limited.41 For example, in the
Western Pacific region, 20 of the 31 nations have legislation
that directly or indirectly bans tobacco advertising, promo-
tion and sponsorship (but many of these are only partial bans
which have not been shown to be effective); 20 require health
warnings; and only 10 have regulations regarding ingredient
disclosure and tar and nicotine levels. The taxation policies in
the region are widely variable (with very high tax rates only
in Singapore and Hong Kong), but almost all countries have
laws banning smoking in selected venues.41 Because these
interventions are often limited in scope and exist in only a
few countries, expansion of these policy initiatives will be
critical to reversing the epidemic in tobacco related morbidity
and mortality unfolding in the developing world. However,
enforcement of laws banning smoking is important to retain
success of this intervention.
Smoking behaviour and lack of knowledge of the
adverse effects of tobacco among service providers
The relatively few studies available describe high levels of
smoking among healthcare professions in developing coun-
tries. For example, in 1999, 37% of Algerian medical students
smoked;49 earlier studies found rates of 61% (in 1996) for
physicians from a hospital in Wuhan, China;50 54% (in 1986)
for hospital workers in Nairobi;51 and 46% (in 1980) for male
physicians in a region of Sudan.52 Smoking by health
professionals is a barrier to implementing cessation inter-
ventions in the healthcare system since service providers are
key to initiating, designing, and implementing any such
programme. Even if these clinicians assess smoking status
and provide advice, they may not be seen as credible if their
patients know they smoke.
Health professionals in developing countries, as is fre-
quently true for policy makers and the general public, are
often poorly informed about the health impacts of tobacco.
The lack of country specific research data and a failure to
disseminate information through official reports contributes
to their lack of knowledge and a potential complacency about
tobacco as a health issue.47 Competing health priorities,
particularly those where the health effect is more proximal in
time to the behaviour,47 also contribute to a lack of action by
health providers. For example, in Africa deaths from the HIV/
AIDS epidemic outstrip those from tobacco and are perceived
as a more immediate problem.41
Deficiencies in the healthcare system and its
infrastructure
The inadequate organisation of the public health system in
many developing countries contributes to the general lack of
information about the extent to which tobacco use causes
harm. Political instability in some countries also works
against public health action. In addition, the healthcare
infrastructure in developing countries often lacks adequate
record keeping, inhibiting the ability of the public health
Smoking cessation in developing countries 625
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community to demonstrate the magnitude of the tobacco
problem. An improved vital statistics system, for example, is
critical to the documentation of deaths due to tobacco.32
Finally, healthcare systems in both developing and developed
countries are not structured to effectively care for people with
chronic diseases.53
The guideline on the clinical treatment of tobacco use
developed by the US Public Health Service (USPHS)22
suggests implementation of the ‘‘5As’’ approach:
N Ask (about tobacco use);
N Advise (users to quit);
N Assess (interest in quitting);
N Assist (the quit attempt); and
N Arrange (follow up).
In developing countries, however, providers are generally
unfamiliar with such brief clinical interventions and many
developing countries do not have an integrated system of care
that can implement the necessary system changes or provide
information and support to the providers. Thus, reaching a
large proportion of smokers through the healthcare systems
may be difficult.
Efforts are currently underway to reach healthcare
providers worldwide through Internet based dissemination
of information54 and training.55 Some training has also been
accomplished through conference venues such as the World
Conference on Tobacco or Health.56 Unfortunately, an
inability to access these types of support could slow the
dissemination of clinical best practices to developing coun-
tries.
Lack of general infrastructure
In many developing countries progress is hindered by a lack
of technology and a weak infrastructure. In many developed
countries telephone counselling using quit lines, for example,
has proved effective,22 2757 and California’s statewide quit line
has been shown in several studies to double quit rates,57 58 but
such an approach may not be feasible in a developing
country. If much of the population does not have a home
telephone, and existing telephone lines may not be always
accessible, such a strategy would not be practical. It would be
even more difficult to encourage smokers to use such services
if fees were charged, but the government might not be in a
position to deliver free cessation services and medications
because of the financial constraints mentioned above.
Industry action
While the public health community is busy trying to reduce
tobacco use, the tobacco industry continues to market its
products aggressively. Advertising invokes themes of indivi-
dual rights, independence, and modernisation. Advertisers
attempts to ‘‘create a fantasy of sophistication, pleasure, and
social success’’.28 59 In developing countries the fantasy being
sold is often American or European culture.28 59 For example,
in many Asian cities beautiful models promote free Western
brand tobacco and other giveaways associated with the West
in restaurants, bars and discos.60 Data are mixed on the effect
of advertising on increasing tobacco consumption, but the
stronger studies appear to show a small increase in
consumption with advertising.26 28 The tobacco industry has
increased its advertising in conjunction with expanded
tobacco control programmes, and a California study sug-
gested that such actions reduced the effectiveness of such a
programme.34 The industry has also sponsored youth anti-
smoking campaigns. For example, in 2001 the Hong Kong
tobacco industry sponsored a youth tobacco prevention
programme with a 3 year budget of HK$18 million
(US$2.31 million). Data from the US, however, suggest that
such industry sponsored interventions are not effective in
reducing youth smoking and may even lead to increases in
such behaviour.61
Industry lobbying can also impede action on tobacco
prevention and control policies. In the Czech Republic the
tobacco industry commissioned an economic analysis for
policy makers which reported that smoking cigarettes could
save the government money (through early deaths that
eliminate pension costs).62 Recent convictions of former
industry executives in the USA and in Hong Kong provide
evidence of industry involvement in smuggling.35
The industry also minimises the health impacts of tobacco,
even in developed countries where the problem has been well
documented.63 64 For example, in depositions in 2002 to the
US Department of Justice, tobacco industry chief executive
officers stated that they did not believe there was proof that
smoking causes disease or that nicotine is addictive.63
WHAT PUBLIC HEALTH AND OTHER HEALTHCARE
PROFESSIONALS SHOULD AND COULD DO
Public health professionals can contribute to policy making
by identifying important health problems caused by tobacco,
providing evidence of the effectiveness of specific cessation
interventions, and suggesting appropriate models for imple-
menting them. Implementation will require collaboration of
multiple sectors. Public health professionals should not limit
themselves to medical approaches and should consider
broader policy approaches as well.
Cessation interventions targeting health professionals
Interventions to reduce smoking among healthcare providers
are an important first step. As already mentioned, the
prevalence of smoking is high among medical professionals
and teachers in some developing countries (such as
China).18 65 Thus, any cessation strategy should attempt to
reach these population groups first, so that they can serve as
role models for others and also promote cessation services in
healthcare settings and schools. Although reaching these
groups may require some resources, it is essential if progress
is to be made.
Strengthening national commitment
Strengthening the commitment of the national government
is essential to implementing a more comprehensive approach
to cessation in both developed and developing countries. This
could be done by developing a broader policy framework
including a mix of three main strategies: a public health
approach; a health systems approach; and a surveillance,
research and information approach.31 Brazil, Thailand, Qatar,
and South Korea have made a strong commitment to
controlling tobacco using different strategies which include
training of smoking cessation service providers in Thailand,32
a demonstration project under the ‘‘Healthy City’’ campaign
in South Korea,66 smoking cessation clinics in Qatar,31 and
highlighting of smoking cessation as a key policy within the
National Tobacco Control Programmes in Brazil.31 Combining
objectives for tobacco control with political commitment
could accelerate action. In Uganda, for example, the 50%
reduction in the seroprevalence of HIV over 4 years was
accomplished with this strategy.67
Developing a model for developing countries
There is no single cessation model in developed coun-
tries,26 30 32 40 68 69 but country specific models generally consist
of a selection of strategies such as price increases, media
campaigns, smoke free policies, reducing the out-of-pocket
costs of treatment, providing counselling and medication
through the healthcare system, telephone quit lines, adver-
tising bans, and stronger warning labels. Policies reach large
numbers of people and can change social norms around
626 Abdullah, Husten
www.thoraxjnl.com
 on 8 November 2006 thorax.bmj.comDownloaded from 
tobacco use.26 27 In general, effective policies are very cost
effective and some are revenue generating (taxation).70 In
addition, some policies (such as taxation) may both increase
cessation and decrease initiation,26 27 creating further effi-
ciencies. However, the smoking cessation models used in
developed countries may have mixed applicability in the
developing world. Although many policy changes (such as
increased tobacco taxes, smoke free policies, advertising
bans, stronger warning labels, and smuggling controls) can
be applied in most countries, more costly interventions (such
as telephone quit lines, sustained paid mass media cam-
paigns, and provision of medication) may have limited
applicability in the developing world.32 In addition, interven-
tions through the healthcare system may be limited by high
smoking rates among healthcare providers, competing health
priorities, and lack of awareness of the adverse health and
economic costs of tobacco use. Thus, any model should be
tested locally for its applicability, acceptance and effective-
ness, particularly in resource poor settings. Population
specific programmes71–74 that are culturally sensitive have
been effective among different population groups elsewhere.
Moreover, the social marketing role of radio and television
networks—for example, the Star television network of
Singapore and the Bollywood television industry—could also
be tested as potential vehicles to promote smoking cessation
in developing countries, which was very effective for
promoting condom use in Asia and Africa.
Changing the social acceptability of smoking
Some societies still consider smoking to be an indication of
higher social class and, in China and Vietnam, many people
buy cigarettes as a gift for superiors or older members of the
family. Its addictive qualities notwithstanding, tobacco use is
strongly influenced by the social conventions, customs, and
norms of society or population groups within a country26 75 76
and is subject to changes in the social environment.26 73
Encouraging people to stop smoking is unlikely to have an
optimal impact unless efforts are made simultaneously to
promote social norms that support cessation; countermarket-
ing campaigns, media advocacy, and smoke free policies are
important tools for changing such norms.26 30 73 75 Initiatives
to change the societal values towards tobacco use must
therefore be a priority. Initiatives to increase awareness of the
hazards of tobacco use are possible in developing countries,
particularly lower cost efforts such as official reports and
requiring or strengthening warning labels on tobacco
products.46 Higher cost initiatives such as sustained mass
media campaigns may be more difficult.32
Strengthening community participation
Data on community interventions come primarily from
developed countries.25 26 32 Ideally, community programmes
should be comprehensive and intervene through multiple
social structures.26 30 75 In the US the Arizona cessation plan
(which requires linkage between community cessation
services and the telephone quit line) increased the amount
of advice to quit given by healthcare providers and reduced
the prevalence of smoking.77 The tobacco prevention and
control programme in Massachusetts, which included a mass
media campaign, quit line, and community cessation
programmes, has doubled the percentage of smokers plan-
ning to quit in the next 30 days in 4 years.78 Community
intervention programmes in developing countries such as
India (community intervention consisting of health profes-
sional advice, mass media campaign, and cessation camps),79
South Africa (which requires community members to be
trained to deliver smoking cessation programmes and specific
advice to smokers),80 and Fiji (longer term collaborative and
village empowerment methods)81 were effective in promoting
quitting smoking.
The World Bank estimated the cost of essential interven-
tions (including tobacco control) at $4 per capita in low
income countries,34 so comprehensive community interven-
tions may not be feasible in developing countries without the
provision of additional resources.34 Smaller scale efforts by
community based organisations or health centres could
promote smoking cessation by (1) promoting a smoke free
environment, (2) providing social support to smokers as they
try to quit and, in some cases, (3) financing nicotine
dependence treatments for the poor. Volunteers in religious
centres such as mosques and churches could also provide
brief counselling for cessation.
Integrating smoking cessation service with other
healthcare services
Conducting local research on the hazards of tobacco use is
moderately feasible in developing countries but may require
outside resources.34 The National Institutes of Health Fogarty
Center tobacco grants82 are an example of this type of
assistance for developing local research capacity. This grant
programme supports international cooperation between
investigators in the US and other high income nations and
scientists and low and/or middle income nations; the major
portion of the research must be conducted in a low or middle
income country and more than 50% of the direct costs must
be used in the low or middle income nation(s) for research or
strengthening the research capacity of foreign institutions.
Because developing countries face enormous financial
difficulties in merely maintaining their existing healthcare
services and the experience in the US suggests that targeted
smoking cessation clinics are not well used and have limited
impact,83 84 it might be more feasible and cost effective for
them to integrate smoking cessation into other healthcare
programmes such as tuberculosis, HIV/AIDS, cancer control,
cardiovascular disease control, or family planning and
maternal health.34 Where self-medication and relying on
pharmacists for health information is common, brief coun-
selling interventions by pharmacists could be another early
strategy.25 Providing smoking cessation services such as
counselling, medication, education materials, and follow up
arrangements in the same way as interventions for other
chronic diseases22 85 may be a way of integrating treatment
for smoking into the general delivery of health care. Public-
private collaboration would be useful in this regard.
Specifying the role of healthcare professionals
Helping health professionals (doctors, nurses, physiothera-
pists) to understand the addictive properties of tobacco is
important in making them appreciate the need for treatment
and the key role that healthcare providers play in increasing
cessation rates. As in many countries in the West,86 smoking
cessation is not included in the educational curriculum of
medical or other health professionals in many developing
countries.87 As a result, health professionals often lack the
expertise to deal with tobacco.
Studies have shown that simple advice to quit smoking is
an effective intervention; it is also one that can be effectively
provided by a variety of health professionals.22 In developing
countries an attempt should be made to encourage health
professionals of all types (such as pharmacists) to identify
tobacco users and provide brief advice to quit, in spite of the
challenges imposed by the fragmented healthcare systems in
these countries. Service providers and policy makers need to
determine how to integrate brief cessation advice and more
intensive cessation services and products within the health
service delivery system in resource poor countries and how to
encourage people to use these services. Hospitals may be a
good setting in which to begin since patients receive
treatment in a more systematic way in this setting.
Smoking cessation in developing countries 627
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Developing guidelines
The development of practice guidelines by professional
groups encourages clinicians to maintain certain standards
in their service delivery.88 Several available guidelines make
recommendations for intervening with tobacco users,21–23 but
local guidelines are often viewed as desirable as they
encourage local providers to ‘‘buy into’’ them. Not surpris-
ingly, however, few guidelines on the treatment of smoking
have been created within developing countries; if a decision
is made to draft them, it is important that different sectors
(various healthcare professionals and healthcare system
administrators, both public and private) be included in the
process.
Mobilising the business community
The business community requires a strong workforce, and
reducing the number of smokers in the workplace would
mean potential savings from decreased absences for smoking
related illness, reduced costs for hospitalisation, and lower
retraining costs due to early deaths.4 89 Workplace strategies
for other purposes have a good track record in some
developing countries in Asia; China, for example, has a
sophisticated workplace population control programme
which has dramatically affected its demographic transition.90
In Thailand a business coalition on AIDS established in 1993
offers a workplace HIV education programme to each tier
within the business organisation.91 Similar programmes have
been effective in promoting HIV prevention campaigns
among African populations.92 Mobilising the business com-
munity to promote smoking cessation could potentially
improve the reach and impact of cessation interventions.
Financial incentives
An important factor to consider is whether smokers should
have to pay for cessation counselling or medication. In many
developing countries the price of nicotine replacement
therapy is high.25 Studies have shown that reducing the
out-of-pocket cost of treatment increases both the use of
treatment and number of successful quitters.27 93 Although
the cost of pharmaceuticals is a major barrier for resource
poor countries, data show that treatment (including medica-
tion) is cost effective even in low income countries.25 The
price of medication varies widely by country;25 government
negotiation to reduce the price of tobacco cessation medica-
tions in resource poor countries, which would parallel earlier
actions on antiretroviral drugs, is one option.94 Waiving the
government tax on medications or producing them locally, as
has been done in China in the case of antiretroviral drugs for
HIV, is another option.95 Still another strategy is to include at
least one medication for tobacco treatment on the WHO list
of essential drugs.
Collaboration between countries
Developing countries should initiate smoking cessation
programmes within the framework of the individual coun-
try’s needs and available resources, and should share their
strategies with other countries with similar socioeconomic
and cultural backgrounds. Research on effective approaches
could be translated into nationwide programmes and
policies. International funding support would most likely be
necessary to help develop any initial programmes, as most
countries in the developing world do not have enough
resources to initiate extensive programmes.
International initiatives
International collaboration will be crucial in promoting
smoking cessation in the developing world. Most developing
countries are resource poor and their governments may not
consider smoking cessation a high priority when compared
with other pressing problems. The WHO, World Bank,
International Monetary Fund (IMF), Gates Foundation,
and other global institutions could promote the importance
of cessation and support initiatives (particularly policy
initiatives) to increase cessation in developing countries.
For example, it has been proposed that international agencies
could make the existence of tobacco control policies a
condition of financial packages.34 Initiatives with a multi-
national focus are other options. As an example of an
ongoing project, a global cessation media campaign is being
developed in conjunction with WHO.96 Developing a multi-
nationally funded initiative is another option.97 The WHO
Framework Convention on Tobacco Control could play a
crucial role in taking these initiatives. However, any interna-
tional initiative should not undermine the resources badly
needed to support many more pressing threats posed by
infectious diseases such as HIV, tuberculosis, and malaria in
many developing countries.
CONCLUSION
Policy makers should be informed that tobacco control is
essential to improve population health and that even modest
reductions in the disease burden of tobacco will bring highly
significant gains. Cessation is vital to any tobacco control
programme. Some immediate actions are possible, such as
expanding smoke free policies, increasing taxes on tobacco
products, implementing or strengthening warning labels,
targeting physicians and teachers for cessation interventions,
and integrating brief counselling into other healthcare
services (such as maternal and child health, tuberculosis,
and HIV programmes). Interventions that have significant
associated costs, however—such as quit lines, reducing the
cost of medication, and sustained media campaigns—may
require dedicated funding from tobacco taxes or interna-
tional assistance.34 Experience in developed countries has
shown that involvement of the private sector and other
interest groups can lead to successful policy change.98 Policy
initiatives should be integrated with community wide
tobacco control interventions that focus on employers, health
providers, and the community.75 International bodies such
as WHO, the World Bank, the IMF, or the Gates Founda-
tion could initiate pilot projects to promote smoking cessa-
tion in the developing world. Lessons learned from the
experience of developed countries and any existing current
programmes in developing countries should be consulted in
designing these programmes. Lessons learned in the devel-
opment of other public health programmes (such as HIV/
AIDS control programmes) in developing countries should
also be used as models. Global support and strong commit-
ment, especially from international organisations and donor
agencies, will be crucial. Furthermore, success of a tobacco
cessation programme in developing countries will rely greatly
on the autonomy and transparency of those organisations
that are in a position to initiate and implement these
programmes.
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